Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-03-16

Clinical Trial Update: Efficacy of Two Algae Formulations on Lipid Metabolism, Inflammation and Oxidative Stress Status in Individuals With Psoriasis [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating two algae formulations in psoriasis has completed, examining effects on lipid metabolism, inflammation, and oxidative stress markers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Algae formulation 1
  • Algae formulation 2

Snippet

Sponsor: University of Manitoba | Conditions: Psoriasis | Phase 1 | Status: COMPLETED